Researchers in the UF College of Pharmacy teamed with collaborators in Singapore to study a novel drug candidate with marine origins as a new method to prevent or treat vision loss.
The American Chemical Society, or ACS, has appointed Jane Aldrich, Ph.D., as a fellow. ACS will honor Aldrich, along with the rest of its 2019 fellows — a cohort of 70 from organizations as diverse as GlaxoSmithKline, NASA and Massachusetts Institute of Technology — at its National Meeting & Expo, August 25–29 in San Diego. Aldrich, a…
Recent reports of babies born with opioid withdrawal symptoms after their mothers used kratom during pregnancy have generated much concern about the medicinal.
Luesch presented on the expanding chemical space for drug discovery at the conference in Kuwait City.
The grant will bolster research on Mitragyna speciosia, or kratom, and its potential to treat opioid misuse and physical dependence.
UF researchers discovered their compounds induced rapid iron starvation through a series of experiments using novel compounds known as halogenated phenazines, or HPs.
New research reveals two common naloxone products remain chemically stable after their expiration dates.
The 10 medicinal chemistry faculty currently serve as principal investigators on 18 different federally funded grants worth more than $18.4 million.
A UF College of Pharmacy researcher team led by Dr. Hendrik Luesch recently developed a novel molecule based on marine cyanobacteria, Apra S10, to target pancreatic cancer cells.
With the funding from the Maximizing Investigators’ Research Award, Ding aims to access and expand chemical diversity of microbes through the use of new, innovative strategies.